# Prostate Interstitial Brachytherapy With I125 Implant With Target Dose Supplementation in the Tumor Volume Guided by TRINITY® PERINE 3D System

> **NCT05322356** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Grenoble** · enrollment: 15 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** Interstitial Brachytherapy of the Prostate With Iodine 125 Implant With Target Dose Supplementation in the Tumor Volume Guided by the TRINITY® PERINE 3D

## Key facts

- **NCT ID:** NCT05322356
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-04
- **Primary completion:** 2025-07-25
- **Final completion:** 2026-09
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05322356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05322356, "Prostate Interstitial Brachytherapy With I125 Implant With Target Dose Supplementation in the Tumor Volume Guided by TRINITY® PERINE 3D System". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05322356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*